Susan E. Kiefer

2.0k total citations · 1 hit paper
21 papers, 1.4k citations indexed

About

Susan E. Kiefer is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Susan E. Kiefer has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Susan E. Kiefer's work include Melanoma and MAPK Pathways (9 papers), Synthesis and biological activity (5 papers) and Computational Drug Discovery Methods (5 papers). Susan E. Kiefer is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Synthesis and biological activity (5 papers) and Computational Drug Discovery Methods (5 papers). Susan E. Kiefer collaborates with scholars based in United States, Switzerland and Germany. Susan E. Kiefer's co-authors include Kevin Kish, John A. Newitt, Dianlin Xie, Julie E. Scheffler, John S. Sack, John S. Tokarski, Yaqun Zhang, Louis J. Lombardo, Herbert E. Klei and Janet Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Susan E. Kiefer

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants

2006 522 citations John S. Tokarski, John A. Newitt et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan E. Kiefer United States	14	622	404	282	237	226	21	1.4k
Kevin Kish United States	20	930 1.5×	433 1.1×	295 1.0×	381 1.6×	305 1.3×	38	2.0k
Stephen C. Cosenza United States	23	1.1k 1.8×	296 0.7×	212 0.8×	460 1.9×	97 0.4×	55	2.0k
John S. Tokarski United States	23	776 1.2×	419 1.0×	334 1.2×	690 2.9×	63 0.3×	43	2.0k
Dianlin Xie United States	14	437 0.7×	411 1.0×	306 1.1×	185 0.8×	32 0.1×	20	1.1k
Michael J. Munchhof United States	16	938 1.5×	267 0.7×	175 0.6×	413 1.7×	81 0.4×	30	1.6k
Lily L. Remsing Rix United States	19	902 1.5×	465 1.2×	358 1.3×	260 1.1×	27 0.1×	28	1.8k
Steven K. Davidsen United States	31	1.9k 3.0×	209 0.5×	116 0.4×	1000 4.2×	82 0.4×	80	3.0k
Giorgio Caravatti Switzerland	26	1.5k 2.4×	206 0.5×	215 0.8×	660 2.8×	36 0.2×	45	2.3k
Melanie Valenti United Kingdom	30	1.7k 2.7×	158 0.4×	131 0.5×	383 1.6×	63 0.3×	61	2.6k
M.A. Argiriadi United States	13	357 0.6×	77 0.2×	77 0.3×	161 0.7×	66 0.3×	22	971

Countries citing papers authored by Susan E. Kiefer

Since Specialization

Citations

This map shows the geographic impact of Susan E. Kiefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Kiefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Kiefer more than expected).

Fields of papers citing papers by Susan E. Kiefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Kiefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Kiefer. The network helps show where Susan E. Kiefer may publish in the future.

Co-authorship network of co-authors of Susan E. Kiefer

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Kiefer. A scholar is included among the top collaborators of Susan E. Kiefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Kiefer. Susan E. Kiefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sack, John S., Mian Gao, Susan E. Kiefer, et al.. (2016). Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor. Acta Crystallographica Section F Structural Biology Communications. 72(2). 129–134. 47 indexed citations

Tebben, Andrew J., Mian Gao, Dianlin Xie, et al.. (2016). Crystal structures of apo and inhibitor-bound TGFβR2 kinase domain: insights into TGFβR isoform selectivity. Acta Crystallographica Section D Structural Biology. 72(5). 658–674. 22 indexed citations

Kiefer, Susan E., ChiehYing Chang, Mian Gao, et al.. (2014). The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor. Acta Crystallographica Section F Structural Biology Communications. 70(2). 173–181. 20 indexed citations

Wrobleski, Stephen T., Shuqun Lin, T. G. Murali Dhar, et al.. (2013). The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. Bioorganic & Medicinal Chemistry Letters. 23(14). 4120–4126. 15 indexed citations

Dyckman, Alaric J., Tianle Li, Sidney Pitt, et al.. (2011). Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(15). 4633–4637. 9 indexed citations

Kish, Kevin, Patricia A. McDonnell, Valentina Goldfarb, et al.. (2011). Cloning, purification, crystallization and preliminary X-ray analysis of the catalytic domain of human receptor-like protein tyrosine phosphatase γ in three different crystal forms. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 67(7). 768–774. 2 indexed citations

Sheriff, S., Brett R. Beno, Weixu Zhai, et al.. (2011). Small Molecule Receptor Protein Tyrosine Phosphatase γ (RPTPγ) Ligands That Inhibit Phosphatase Activity via Perturbation of the Tryptophan–Proline–Aspartate (WPD) Loop. Journal of Medicinal Chemistry. 54(19). 6548–6562. 18 indexed citations

Lin, Shuqun, Stephen T. Wrobleski, John Hynes, et al.. (2010). Utilization of a nitrogen–sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(19). 5864–5868. 26 indexed citations

Das, Jagabandhu, Robert V. Moquin, Alaric J. Dyckman, et al.. (2010). 5-Amino-pyrazoles as potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 6886–6889. 19 indexed citations

10.

Kiefer, Susan E., et al.. (2010). Citrus Flavonoids with Skin Lightening Effects - Safety and Efficacy Studies. 8 indexed citations

11.

Sack, John S., Kevin Kish, Matthew Pokross, et al.. (2008). Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase. Acta Crystallographica Section D Biological Crystallography. 64(7). 705–710. 10 indexed citations

12.

Liu, Chunjian, James C. Lin, Sidney Pitt, et al.. (2008). Benzothiazole based inhibitors of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1874–1879. 47 indexed citations

13.

Das, Jagabandhu, Robert V. Moquin, Sidney Pitt, et al.. (2008). Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2652–2657. 37 indexed citations

14.

Constantine, Keith L., Luciano Mueller, William J. Metzler, et al.. (2008). Multiple and Single Binding Modes of Fragment-Like Kinase Inhibitors Revealed by Molecular Modeling, Residue Type-Selective Protonation, and Nuclear Overhauser Effects. Journal of Medicinal Chemistry. 51(19). 6225–6229. 11 indexed citations

15.

Li, Tao, Susan E. Kiefer, Dianlin Xie, et al.. (2008). Time-resolved limited proteolysis of mitogen-activated protein kinase-activated protein kinase-2 determined by LC/MS only. Journal of the American Society for Mass Spectrometry. 19(6). 841–854. 5 indexed citations

16.

Tokarski, John S., John A. Newitt, Janet Cheng, et al.. (2006). The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants. Cancer Research. 66(11). 5790–5797. 522 indexed citations breakdown →

17.

Tokarski, John S., John A. Newitt, Francis Y. Lee, et al.. (2004). The Crystal Structure of Abl Kinase with BMS-354825, a Dual SRC/ABL Kinase Inhibitor.. Blood. 104(11). 553–553. 21 indexed citations

18.

Hefta, Stanley A., et al.. (2003). A high-yield method to extract peptides from rat brain tissue. Analytical Biochemistry. 315(2). 183–188. 6 indexed citations

19.

Sack, John S., Kevin Kish, Chihuei Wang, et al.. (2001). Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proceedings of the National Academy of Sciences. 98(9). 4904–4909. 357 indexed citations

20.

Emerson, S. Donald, Vincent Madison, Robert E. Palermo, et al.. (1995). Solution Structure of the Ras-Binding Domain of c-Raf-1 and Identification of Its Ras Interaction Surface. Biochemistry. 34(21). 6911–6918. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact